Search results
Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up
Zacks via Yahoo Finance· 2 months agoIterum (ITRM) stock rises as the company gears up to submit a regulatory application to the FDA...
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 weeks agoIterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript March 28, 2024 Iterum...
Iterum Therapeutics Shares Are Surging - Read Why
Benzinga via Yahoo Finance· 2 years agoIterum Therapeutics plc (NASDAQ: ITRM) has agreed with the FDA under the special protocol assessment (SPA) process on the design, endpoints, and...
All You Need to Know About Iterum Therapeutics PLC (ITRM) Rating Upgrade to Strong Buy
Zacks via Yahoo Finance· 1 year agoIterum Therapeutics PLC (ITRM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing...
Iterum Therapeutics (NASDAQ:ITRM) Has Debt But No Earnings; Should You Worry?
Simply Wall St. via Yahoo Finance· 2 years agoHoward Marks put it nicely when he said that, rather than worrying about share price volatility,...
Theravance's (TBPH) Q1 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 11 months agoTheravance Biopharma TBPH reported first-quarter 2023 net loss of 32 cents per share, wider than the...
Nektar Therapeutics (NKTR) Q1 Earnings & Revenues Beat
Zacks via Yahoo Finance· 11 months agoNektar Therapeutics NKTR reported a loss (excluding non-cash goodwill and other impairment charges)...
Steven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLC
GuruFocus.com via Yahoo Finance· 3 months agoOn January 30, 2024, Steven Cohen (Trades, Portfolio)'s Point72 Asset Management made a significant...
Baudax (BXRX) Up on New Neuromuscular Blocking Agent Study Data
Zacks via Yahoo Finance· 11 months agoNew data from Baudax's (BXRX) study on BX1000 confirms greater comparability of the highest dose of...
Avalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89%
Zacks via Yahoo Finance· 10 months agoAvalo (AVTX) announces that it failed to meet the primary endpoint in its mid-stage poorly...